Chairman of the Board

Bengt Dahlström, Associate Professor

Bengt Dahlström is Associate Professor in Pharmacokinetics and Drug Therapy from Uppsala University, Sweden and has published over 50 scientific papers in this area. He is an expert in pharmacokinetics, drug research and development with over 40 years experience from leading positions in Pharmaceutical companies and CROs. He is co-founder of 3 leading Clinical Research Organizations: CTC AB, PMC AB and MiniDoc AB. 

Other assignments: Board member in CTR´s subsidiaries.

Board members

Folke Sjöberg, MD., Consultant, Professor.

Co-Director, the Burn Center at Linköping University Hospital,Chief of staff Department of Anesthesiology and Intensive Care, Linköping University hospital (1999-2004) President European Burns Association (EBA)(2007 – 2009). Director Research and Development; the Swedish Intensive Care registry (2009 – 2013). Deputy Vice Chancellor Linköping University (2015-2018). President of the World Burn Organization (International Society for Burn Injuries ISBI). Previous member of the ”Burn Center Verification Committee” American Burns Association.
Supervised > 40 PhD students. Primary investigator > 300 clinical trials, ranging from phase I-IV.
Author/co-author of more than 350 original peer reviewed scientific papers, including book chapters and books.
He is co-founder of CTC AB. 

Other assignments: Board member in CTR´s subsidiaries.

Hans Andreasson MSc, MPhil, MBA INSEAD.

Hans is Investment Director at the Sixth Swedish National Pension Fund. He has 35 years’ operational and investment experience from the life science industry including a tenure as management consultant at ADL, various senior management positions at Pharmacia & Upjohn and partner at Scandinavian Life Science Venture. Hans has broad international work and board experience of building companies in a changing environment.

Other assignments: Board member of SLS Invest AB.   

Peter Weiderman

Peter Weiderman is an entrepreneur and investor with a business degree from Uppsala University. He has over 30 years of experience from investing and executive positions. 2005 he founded the investment company Atnotera AB, investing in healthcare, care and education. Cofounder of among others Ambea, Atvexa, Vårdapoteket and Atviva.

Other assignments: Member of the Board – Atviva AB, Member of the Board – Atvexa AB, Member of the Board – My Clinical Outcomes Ltd (MCO), Member of the Board – Atveda AB, Member of the Board – Center for Translational Research AB, Chairman – Atnotera AB.